Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Psoriasis: HELP
Articles by Vinod Chandran
Based on 129 articles published since 2008
||||

Between 2008 and 2019, V. Chandran wrote the following 129 articles about Psoriasis.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6
126 Minor Gene expression differences between psoriasis patients with and without inflammatory arthritis. 2015

Pollock, Remy A / Abji, Fatima / Liang, Kun / Chandran, Vinod / Pellett, Fawnda J / Virtanen, Carl / Gladman, Dafna D. ·Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Research Institute, University of Toronto, Toronto, Ontario, Canada. · Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. · Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Research Institute, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · University Health Network Microarray Centre, Toronto, Ontario, Canada. · Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Research Institute, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: dafna.gladman@utoronto.ca. ·J Invest Dermatol · Pubmed #25243786.

ABSTRACT: -- No abstract --

127 Minor Spondyloarthritis: CASPAR criteria in early psoriatic arthritis. 2012

Chandran, Vinod. · ·Nat Rev Rheumatol · Pubmed #22825727.

ABSTRACT: -- No abstract --

128 Unspecified Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. 2012

Fitzgerald, Oliver / Chandran, Vinod. ·Department of Rheumatology, St Vincent’s University Hospital and Conway Institute, University College Dublin, Dublin, Ireland. oliver.fitzgerald@ucd.ie ·J Rheumatol · Pubmed #22298273.

ABSTRACT: Biomarkers may be used to screen patients with psoriasis for psoriatic arthritis (PsA) and to assess disease activity and severity. Candidate biomarkers should fulfil the key features of the OMERACT (Outcome Measures in Rheumatology) filter, that is, truth, discrimination, and feasibility. A number of biomarkers are currently being investigated in psoriatic disease for important clinical outcomes. Serum high sensitivity C-reactive protein, cartilage oligomeric matrix protein, interleukin 6 (IL-6), osteoprotegerin, matrix metalloprotease-3 (MMP-3), and the ratio of C-propeptide of type II collagen (CPII) to collagen fragment neoepitopes Col2-3/4 (long mono) (C2C) show promise as serum biomarkers that distinguish subjects with PsA from those with psoriasis alone. Serum MMP-3 and melanoma inhibitory activity, synovial fluid IL-1, IL-1 receptor-α, IL-6, IL-8, and chemokine CCL3 and synovial tissue CD3-positive T cells may prove useful as biomarkers of PsA activity. Circulating osteoclast precursors, Dickkopf-1, macrophage colony stimulating factor, receptor activator of nuclear factor-κB ligand, and bone alkaline phosphatase are strong candidates as biomarkers of radiographic change. Prospective studies to identify biomarkers for psoriatic disease are high on the research agenda of the Group for Research and Assessment of Psoriasis and PsA.

129 Minor Expression patterns of natural killer receptor genes in inflamed joints and peripheral blood of patients with psoriatic arthritis. 2011

Pollock, R A / Pellett, F J / Chandran, V / Gladman, D D. · ·Tissue Antigens · Pubmed #21883096.

ABSTRACT: -- No abstract --

Back